These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1093 related articles for article (PubMed ID: 27504006)
1. Orthostatic Hypotension in the ACCORD (Action to Control Cardiovascular Risk in Diabetes) Blood Pressure Trial: Prevalence, Incidence, and Prognostic Significance. Fleg JL; Evans GW; Margolis KL; Barzilay J; Basile JN; Bigger JT; Cutler JA; Grimm R; Pedley C; Peterson K; Pop-Busui R; Sperl-Hillen J; Cushman WC Hypertension; 2016 Oct; 68(4):888-95. PubMed ID: 27504006 [TBL] [Abstract][Full Text] [Related]
2. Orthostatic Hypotension, Cardiovascular Outcomes, and Adverse Events: Results From SPRINT. Juraschek SP; Taylor AA; Wright JT; Evans GW; Miller ER; Plante TB; Cushman WC; Gure TR; Haley WE; Moinuddin I; Nord J; Oparil S; Pedley C; Roumie CL; Whittle J; Wiggers A; Finucane C; Anne Kenny R; Appel LJ; Townsend RR; Hypertension; 2020 Mar; 75(3):660-667. PubMed ID: 31983312 [TBL] [Abstract][Full Text] [Related]
3. Intensive Blood Pressure Targets for Diabetic and Other High-Risk Populations: A Pooled Individual Patient Data Analysis. Aggarwal R; Steinkamp J; Chiu N; Petrie B; Mirzan H Hypertension; 2018 May; 71(5):833-839. PubMed ID: 29531175 [TBL] [Abstract][Full Text] [Related]
4. Association of Orthostatic Hypotension Timing With Clinical Events in Adults With Diabetes and Hypertension: Results From the ACCORD Trial. Juraschek SP; Lipsitz LA; Beach JL; Mukamal KJ Am J Hypertens; 2019 Jun; 32(7):684-694. PubMed ID: 30715100 [TBL] [Abstract][Full Text] [Related]
5. Hypertension Treatment Effects on Orthostatic Hypotension and Its Relationship With Cardiovascular Disease. Juraschek SP; Appel LJ; Miller ER; Mukamal KJ; Lipsitz LA Hypertension; 2018 Oct; 72(4):986-993. PubMed ID: 30354704 [TBL] [Abstract][Full Text] [Related]
7. Orthostatic Hypotension and Risk of Clinical and Subclinical Cardiovascular Disease in Middle-Aged Adults. Juraschek SP; Daya N; Appel LJ; Miller ER; McEvoy JW; Matsushita K; Ballantyne CM; Selvin E J Am Heart Assoc; 2018 May; 7(10):. PubMed ID: 29735525 [TBL] [Abstract][Full Text] [Related]
8. Orthostatic hypotension as a risk factor for incident heart failure: the atherosclerosis risk in communities study. Jones CD; Loehr L; Franceschini N; Rosamond WD; Chang PP; Shahar E; Couper DJ; Rose KM Hypertension; 2012 May; 59(5):913-8. PubMed ID: 22431580 [TBL] [Abstract][Full Text] [Related]
9. Orthostatic Hypotension, Hypertension Treatment, and Cardiovascular Disease: An Individual Participant Meta-Analysis. Juraschek SP; Hu JR; Cluett JL; Ishak AM; Mita C; Lipsitz LA; Appel LJ; Beckett NS; Coleman RL; Cushman WC; Davis BR; Grandits G; Holman RR; Miller ER; Peters R; Staessen JA; Taylor AA; Thijs L; Wright JT; Mukamal KJ JAMA; 2023 Oct; 330(15):1459-1471. PubMed ID: 37847274 [TBL] [Abstract][Full Text] [Related]
10. Average Clinician-Measured Blood Pressures and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus and Ischemic Heart Disease in the EXAMINE Trial. White WB; Jalil F; Cushman WC; Bakris GL; Bergenstal R; Heller SR; Liu Y; Mehta C; Zannad F; Cannon CP J Am Heart Assoc; 2018 Oct; 7(20):e009114. PubMed ID: 30371278 [TBL] [Abstract][Full Text] [Related]
11. Generalizing Intensive Blood Pressure Treatment to Adults With Diabetes Mellitus. Berkowitz SA; Sussman JB; Jonas DE; Basu S J Am Coll Cardiol; 2018 Sep; 72(11):1214-1223. PubMed ID: 30189998 [TBL] [Abstract][Full Text] [Related]
12. Body Position and Orthostatic Hypotension in Hypertensive Adults: Results from the Syst-Eur Trial. Grobman B; Turkson-Ocran RN; Staessen JA; Yu YL; Lipsitz LA; Mukamal KJ; Juraschek SP Hypertension; 2023 Apr; 80(4):820-827. PubMed ID: 36744469 [TBL] [Abstract][Full Text] [Related]
13. Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic Hypertension in Europe Trial Investigators. Staessen JA; Thijs L; Fagard R; O'Brien ET; Clement D; de Leeuw PW; Mancia G; Nachev C; Palatini P; Parati G; Tuomilehto J; Webster J JAMA; 1999 Aug; 282(6):539-46. PubMed ID: 10450715 [TBL] [Abstract][Full Text] [Related]
14. Blood Pressure Lowering With Nilvadipine in Patients With Mild-to-Moderate Alzheimer Disease Does Not Increase the Prevalence of Orthostatic Hypotension. de Heus RAA; Donders R; Santoso AMM; Olde Rikkert MGM; Lawlor BA; Claassen JAHR; J Am Heart Assoc; 2019 May; 8(10):e011938. PubMed ID: 31088188 [TBL] [Abstract][Full Text] [Related]
15. Intensive Versus Standard Blood Pressure Control in SPRINT-Eligible Participants of ACCORD-BP. Buckley LF; Dixon DL; Wohlford GF; Wijesinghe DS; Baker WL; Van Tassell BW Diabetes Care; 2017 Dec; 40(12):1733-1738. PubMed ID: 28947569 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of Optimal Diastolic Blood Pressure Range Among Adults With Treated Systolic Blood Pressure Less Than 130 mm Hg. Li J; Somers VK; Gao X; Chen Z; Ju J; Lin Q; Mohamed EA; Karim S; Xu H; Zhang L JAMA Netw Open; 2021 Feb; 4(2):e2037554. PubMed ID: 33595663 [TBL] [Abstract][Full Text] [Related]
17. Thiazide Use and Cardiovascular Events in Type 2 Diabetic Patients With Well-Controlled Blood Pressure. Tsujimoto T; Kajio H Hypertension; 2019 Dec; 74(6):1541-1550. PubMed ID: 31679424 [TBL] [Abstract][Full Text] [Related]
18. Effects of Intensive Systolic Blood Pressure Lowering on Cardiovascular Events and Mortality in Patients With Type 2 Diabetes Mellitus on Standard Glycemic Control and in Those Without Diabetes Mellitus: Reconciling Results From ACCORD BP and SPRINT. Beddhu S; Chertow GM; Greene T; Whelton PK; Ambrosius WT; Cheung AK; Cutler J; Fine L; Boucher R; Wei G; Zhang C; Kramer H; Bress AP; Kimmel PL; Oparil S; Lewis CE; Rahman M; Cushman WC J Am Heart Assoc; 2018 Sep; 7(18):e009326. PubMed ID: 30371182 [TBL] [Abstract][Full Text] [Related]
19. Target Blood Pressure in Patients with Diabetes: Asian Perspective. Park S; Kario K; Park CG; Huang QF; Cheng HM; Hoshide S; Wang JG; Chen CH; Yonsei Med J; 2016 Nov; 57(6):1307-11. PubMed ID: 27593856 [TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of low blood pressures among patients with diabetes: subgroup analyses from the ONTARGET (ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial). Redon J; Mancia G; Sleight P; Schumacher H; Gao P; Pogue J; Fagard R; Verdecchia P; Weber M; Böhm M; Williams B; Yusoff K; Teo K; Yusuf S; J Am Coll Cardiol; 2012 Jan; 59(1):74-83. PubMed ID: 22192672 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]